Precision Genomics, A Ludwig Enterprises Company
Menu
Precision Genomics delivers never-before-seen capabilities for early diagnosis, prevention and treatment of humanity’s most prevalent diseases. New proprietary mRNA technology and state-of-the-art deep machine learning allow Precision Genomics to provide new insights at the very core of inflammatory dysfunction—forever changing the future of healthcare and medical research.
It’s like a car’s dashboard engine light—for health. The groundbreaking PG Inflammatory Index™ uses mRNA biomarkers to allow healthcare providers to spot disease early, and personalize treatment based on a patient’s individual genetics, choosing the best plan of care the first time. Powered by Artificial Intelligence (AI), the index makes problems visible long before symptoms appear.
The first of its kind. My RNA For Life™ is a preventive dietary supplement, designed to neutralize specific inflammatory genetic markers associated with chronic disease. It allows at-risk patients to take highly-personalized counter-measures through their nutrition, minimizing the chance they’ll develop a severe illness such as cancer, diabetes, heart disease, multiple sclerosis, Parkinson’s or stroke.
The Precision Genomics Statistical Program is revolutionizing the way data creates new understanding in medical research. Leveraging our AI’s highly sophisticated, deep learning capabilities, researches can correlate, analyze and evaluate genomic information and patient phenotypes in ways previously unimaginable. The Results? Uncovering the most hidden patterns of inflammation, dysfunction and disease. Making medical breakthroughs a matter of time: less.
With a truly unique array of new technologies and Bioinformatics, Precision Genomics is set up to become a dominant force in the medical field. From enabling revolutionary research to becoming the premier data bank to Big Pharma—the rolodex of groundbreaking solutions is deep. And thanks to unmatched insight into inflammation, Precision Genomics is always positioned at the heart of medicine’s most decisive problems.
Precision Genomics employs some of the best minds in the field. Meet the key individuals allowing us to make a habit of industry-leading innovation:
Dr. Hausman is an Immunologist and Board-Certified Urological Surgeon with more than 30 years of experience in drug research and development. He worked for some of the best pharmaceutical companies, including Bristol-Myers International, Mead-Johnson Pharmaceutical Co., E.R. Squibb, Medco Research, and Axonyx.
Dr. Ambert is currently Director of Data Science at Nike, Inc. and has extensive experience in data analytics, machine learning, artificial intelligence and applied analytics. Previously, he held positions at the National Library of Medicine and Intel Corp. Dr. Ambert holds a PhD in Biomedical Informatics from Oregon Health & Science University.
Interested in becoming a shareholder? Precision Genomics is always looking to work with investors wanting to help fund our campaign of transforming healthcare forever—and profit in the process.
